HomeCompareIBXNF vs PLD

IBXNF vs PLD: Dividend Comparison 2026

IBXNF yields 200.00% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXNF wins by $113.46M in total portfolio value
10 years
IBXNF
IBXNF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full IBXNF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — IBXNF vs PLD

📍 IBXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXNFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXNF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXNF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXNF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, IBXNF beats the other by $47,111,565.43/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXNF + PLD for your $10,000?

IBXNF: 50%PLD: 50%
100% PLD50/50100% IBXNF
Portfolio after 10yr
$62.64M
Annual income
$32,463,410.73/yr
Blended yield
51.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

IBXNF
No analyst data
Altman Z
5.4
Piotroski
6/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXNF buys
0
PLD buys
0
No recent congressional trades found for IBXNF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXNFPLD
Forward yield200.00%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$119.36M$5.91M
Annual income after 10y$60,176,096.29$4,750,725.19
Total dividends collected$112.49M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IBXNF vs PLD ($10,000, DRIP)

YearIBXNF PortfolioIBXNF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$30,700$20,000.00$11,241$540.96+$19.5KIBXNF
2$90,232$57,383.18$13,019$991.13+$77.2KIBXNF
3$254,173$157,624.56$15,801$1,870.97+$238.4KIBXNF
4$686,927$414,961.74$20,609$3,701.21+$666.3KIBXNF
5$1,783,118$1,048,106.39$29,919$7,867.97+$1.75MIBXNF
6$4,450,613$2,542,677.12$50,631$18,617.74+$4.40MIBXNF
7$10,693,420$5,931,263.38$105,528$51,352.20+$10.59MIBXNF
8$24,760,608$13,318,648.86$287,364$174,449.42+$24.47MIBXNF
9$55,315,649$28,821,798.66$1,081,760$774,280.77+$54.23MIBXNF
10$119,363,841$60,176,096.29$5,908,209$4,750,725.19+$113.46MIBXNF

IBXNF vs PLD: Complete Analysis 2026

IBXNFStock

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Full IBXNF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this IBXNF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXNF vs SCHDIBXNF vs JEPIIBXNF vs OIBXNF vs KOIBXNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.